Syndax Pharmaceuticals (SNDX) Non Operating Income: 2015-2024
Historic Non Operating Income for Syndax Pharmaceuticals (SNDX) over the last 10 years, with Dec 2024 value amounting to $20.9 million.
- Syndax Pharmaceuticals' Non Operating Income fell 374.63% to -$563,000 in Q4 2020 from the same period last year, while for Dec 2020 it was -$1.7 million, marking a year-over-year decrease of 216.29%. This contributed to the annual value of $20.9 million for FY2024, which is 1.55% up from last year.
- As of FY2024, Syndax Pharmaceuticals' Non Operating Income stood at $20.9 million, which was up 1.55% from $20.6 million recorded in FY2023.
- Syndax Pharmaceuticals' 5-year Non Operating Income high stood at $20.9 million for FY2024, and its period low was -$1.7 million during FY2020.
- In the last 3 years, Syndax Pharmaceuticals' Non Operating Income had a median value of $20.6 million in 2023 and averaged $14.6 million.
- In the last 5 years, Syndax Pharmaceuticals' Non Operating Income plummeted by 216.29% in 2020 and then surged by 751.34% in 2023.
- Over the past 5 years, Syndax Pharmaceuticals' Non Operating Income (Yearly) stood at -$1.7 million in 2020, then climbed by 25.42% to -$1.3 million in 2021, then soared by 286.94% to $2.4 million in 2022, then surged by 751.34% to $20.6 million in 2023, then increased by 1.55% to $20.9 million in 2024.